Endobronchial valve block in the treatment of patients with destructive pulmonary tuberculosis and low adherence to therapy with anti-tuberculosis drugs and refusing to stay in hospital
https://doi.org/10.21292/2075-1230-2019-97-12-46-53
Abstract
The objective of the study: to analyze the efficacy of endobronchial valve block (EBV) during out-patient treatment of patients with destructive pulmonary tuberculosis who refused in-patient treatment and therapy with anti-tuberculosis drugs.
Subjects and methods. Treatment outcomes of 129 patients were randomly studied, the patients suffered from destructive pulmonary tuberculosis and demonstrated low adherence to therapy with anti-tuberculosis drugs and staying in hospital. EBV was used in one group (66 patients), and it was not used in patients from another group (63 patients).
Results. The use of EBV in patients with poor adherence to inpatient treatment and chemotherapy allowed achieving sputum conversion in 36 (58.1%) patients and healing of cavities in 43 (65.2%). Among the patients in whom no EBV was used, sputum conversion was achieved in 12 (20.7%) patients (p = 0.001, χ2) and cavities were healed in 14 (22.2%) patients (p = 0.001, χ2). Efficacy and safety of EBV was demonstrated when used on the out-patient basis in the above category of patients.
About the Authors
P. A. FadeevRussian Federation
Pavel A. Fadeev - Head Physician, Chief Expert Phthisiologist of the Far Eastern Federal District.
3, Taezhnaya St., Chita, Zabaykalskiy Kray, 672038
D. V. Krasnov
Russian Federation
Denis V. Krasnov - Doctor of Medical Sciences, Head of Pulmonary Tuberculosis Surgery Department, Head Researcher.
81a, Okhotskaya St., Novosibirsk, 630040
S. V. Sklyuev
Russian Federation
Sergey V. Sklyuev - Candidate of Medical Sciences, Head of Endoscopy Department.
81a, Okhotskaya St., Novosibirsk, 630040
N. G. Grischenko
Russian Federation
Nikolay G. Grischenko - Doctor of Medical Sciences, Thoracic Surgeon.
81a, Okhotskaya St., Novosibirsk, 630040
V. A. Krasnov
Russian Federation
Vladimir A. Krasnov - Doctor of Medical Sciences, Director.
81a, Okhotskaya St., Novosibirsk, 630040
References
1. Vasilyeva I.А., Belilovsky E.M., Borisov S.E., Sterlikov S.А. Incidence, mortality and prevalence as indicators of tuberculosis burden in WHO regions, countries of the world, and the Russian Federation. Tuberculosis and Lung Diseases, 2017, no. 6, pp. 9-21. (In Russ.)
2. Geltser B.I., Shakhgeldyan K.I., Krivelevich E.B., Medvedev V.I., Ermolitskaya M.Z. Certain approaches to efficiency evaluation of the regional TB services. Tuberculosis and Lung Diseases, 2017, no. 12, pp. 28-34. (In Russ.)
3. Krasnov D.V., Petrova Ya.K., Sklyuev S.V., Myshkova E.P. Factors providing impact on the efficiency of valve bronchial block in the comprehensive treatment of destructive pulmonary tuberculosis with concurrent HIV infection. Tuberculosis and Lung Diseases, 2018, no. 8, pp. 25-30. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-8-25-30
4. Lovacheva O.V., Elkin А.V., Zimonin P.E., Krasnov D.V., Krasnov V.А., Levin А.V., Sklyuev S.V., Skornyakov S.N., Stepanov D.V., Tseymakh E.А., Shumskaya I.Yu. Federalnye klinicheskie rekomendatsii po ispolzovaniyu metoda klapannoy bronkhoblokatsii v lechenii tuberkuleza legkikh i ego oslozhneniy. [Federal clinical recommendations on using valve bronchial block in the treatment of pulmonary tuberculosis and its complications]. Moscow, New Terra Publ., 2015, pp. 24. http://roftb.ru/netcat_files/doks2015/rec7.pdf
5. Mordyk А.V., Udalova T.Yu., Sitnikova S.V., Puzyreva L.V., Ledeneva T.N. The personality of the patients with TB/HIV co-infection. Dalnevostochniy Meditsinskiy Journal, 2016, no. 1, pp. 50-53. (In Russ.)
6. Naryshkina S.L., Khromova L.V., Kadyshev S.А. Treatment adherence in patients with concurrent conditions (TB/HIV). Tuberculosis and Lung Diseases, 2011, vol. 88, no. 5, pp. 70. (In Russ.)
7. Popova L.А., Shergina E.А., Lovacheva O.V., Shabalina I.Yu., Bagdasaryan T.R., Sidorova N.F. Changes in the lung functions in the early period of endobronchial valve block in those suffering from chronic destructive tuberculosis. Pulmonoloiya, 2018, vol. 28, no. 3, pp. 332-340. (In Russ.)
8. Revyakina O.V., Filippova O.P., Pavlenok I.V., Mitrofanov R.А. Osnovnye pokazateli protivotuberkuleznoy deyatelnosti v Sibirskom i Dalnevostochnom federalnom okruge. [Main indicators of tuberculosis control activities in the Siberian and Far Eastern Federal Districts]. Novosibirsk, IPTS NGMU Publ., 2019, 96 p.
9. Sinitsyn M.V., Belilovsky E.M., Borisov S.E., Rybka L.N., Danilova I.D., Kotova E.А. Comparative estimation of efficiency of TB patients treatment depending on the HIV status. Tuberkulez i Sotsialno-Znachimye Zabolevaniya, 2016, no. 5, pp. 18-25. (In Russ.)
10. Sklyuev S.V., Krasnov D.V. Evaluation of impact by valve bronchial blocking on the external respiration using the example of infiltrate destructive pulmonary tuberculosis patients. Pulmonoloiya, 2013, no. 5, pp. 49-52. (In Russ.)
11. Tikhonova L.Yu., Sokolova V.V., Tarasyuk I.А., Ekimenko А.M., Cherenkova M.А., Kudlay D.А. Experience of treatment of multiple drug resistant tuberculosis patients with bedaquiline in Amur Region. Tuberculosis and Lung Diseases, 2018, vol. 96, no. 6, pp. 45-50. (In Russ.)
12. Krasnov D.V., Skluev S.V., Petrova Ya.K., Skvortsov D.A., Krasnov V.A., Felker I.G., Grischenko N.G. Modern collapse therapy for pulmonary tuberculosis. Thoracic Surgery Clinics, 2019, vol. 29, no. 1, pp. 47-58.
13. Levin A., Sklyuev S., Felker I., Krasnov D., Tceymach E. Endobronchial valve treatment of destructive multidrugresistant tuberculosis. Intern. J. Tub. Lung Dis., 2016, vol. 20, no. 11, pp. 1539-1545.
Review
For citations:
Fadeev P.A., Krasnov D.V., Sklyuev S.V., Grischenko N.G., Krasnov V.A. Endobronchial valve block in the treatment of patients with destructive pulmonary tuberculosis and low adherence to therapy with anti-tuberculosis drugs and refusing to stay in hospital. Tuberculosis and Lung Diseases. 2019;97(12):46-53. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-12-46-53